C1 Inhibitor (Human) (Cinryze) and Paclitaxel Novaplus
Determining the interaction of C1 Inhibitor (Human) (Cinryze) and Paclitaxel Novaplus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 Inhibitor (Human) (Cinryze)-Paclitaxel protein-bound
- C1 Inhibitor (Human) (Cinryze)-Paclitaxel protein-bound Intravenous
- C1 Inhibitor (Human) (Cinryze)-Pacnex
- C1 Inhibitor (Human) (Cinryze)-Pacnex LP
- C1 Inhibitor (Human) (Cinryze)-Pacnex MX
- C1 Inhibitor (Human) (Cinryze)-Pain Enz Topical
- Paclitaxel Novaplus-C1 Inhibitor (Human) (Haegarda)
- Paclitaxel Novaplus-C1 Inhibitor (Recombinant)
- Paclitaxel Novaplus-C1-Esterase Inhibitor (Human)
- Paclitaxel Novaplus-C1-Esterase Inhibitor (Recombinant)
- Paclitaxel Novaplus-Cabazitaxel
- Paclitaxel Novaplus-Cabazitaxel Intravenous